Concepedia
Statistics
Publications
37
Citations
2.7K
H-Index
26
Active since
1999
Affiliations
AstraZeneca (United Kingdom)(Current)
Loughborough University
AstraZeneca (United States)
AstraZeneca (Sweden)
AstraZeneca (Singapore)
Elaine Cadogan is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryPharmacotherapyBiochemistryMolecular PharmacologyAsthmaOncologyPathologyPhysiology
Publications per year
1999–2024
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
Cristina Cruz, Marta Castroviejo‐Bermejo, Sara Gutiérrez‐Enríquez et al. · Annals of Oncology · 2018 · 410 citations · Full text
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity
Jacqueline H. L. Fok, Antonio Ramos‐Montoya, Mercedes Vázquez–Chantada et al. · Nature Communications · 2019 · 327 citations · Full text
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
Susan Ashton, Young Ho Song, Elaine Cadogan et al. · Science Translational Medicine · 2016 · 213 citations
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer
Alice Lallo, Kristopher K. Frese, Christopher J. Morrow et al. · Clinical Cancer Research · 2018 · 155 citations · Full text
Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically
Lucy C. Riches, Antonio G. Trinidad, Gareth Hughes et al. · Molecular Cancer Therapeutics · 2019 · 155 citations · Full text
1–5 of 37